2020–2021 BCSC Basic and Clinical Science Course™
1 Update on General Medicine
Chapter 2: Endocrine Disorders
Highlights
-
Metabolic syndrome is a serious health condition that affects about 23% of adults in the United States, putting them at higher risk of cardiovascular disease, diabetes mellitus, stroke, and diseases related to buildup of fatty plaque in artery walls.
-
Diabetes mellitus is a group of metabolic diseases that increase the risk of microvascular and macrovascular complications.
-
Teprotumumab, an investigational drug, may slow progression of ophthalmopathy in patients with moderate to severe thyroid eye disease.
Excerpted from BCSC 2020-2021 series: Section 1 - Update on General Medicine. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.